Heart Transplant Rejection
Also known as: Rejection Heart Transplant / Cardiac transplant rejection (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB09312 | Antilymphocyte immunoglobulin (horse) | A primarily IgG immune globulin used to manage allograft rejection in renal transplant patients. |
DB00091 | Cyclosporine | A steroid-sparing immunosuppressant used in organ and bone marrow transplants as well as inflammatory conditions such as ulcerative colitis, rheumatoid arthritis, and atopic dermatitis. |
DB01590 | Everolimus | A mammalian target of rapamycin (mTOR) kinase inhibitor used to treat various types of malignancies. |
DB00877 | Sirolimus | An mTOR inhibitor immunosuppressant used to prevent organ transplant rejections, treat lymphangioleiomyomatosis, and treat adults with perivascular epithelioid cell tumors. |
DB00864 | Tacrolimus | A calcineurin inhibitor used to prevent organ transplant rejection and to treat moderate to severe atopic dermatitis. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00864 | Tacrolimus | 2 | Active Not Recruiting | 1 |